Jim Kublin
Executive Director · University of Washington School of Medicine
Credentials: · · ·
History
- 1988–1990
Public Health and General Preventive Medicine
Johns Hopkins School of Public Health
1980–1984
Research
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
Science · 2022 · 986 citations
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
New England Journal of Medicine · 2021 · 480 citations
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine
New England Journal of Medicine · 2013 · 480 citations
74 papers
43 papers
27 papers
25 papers
20 papers
20 papers
17 papers
- NG
17 papers
Grants
- 2017–2028
Annual HVTN Translational HIV Early Stage Investigator (ESI) Conference
NIH Office of the Director · R13
Contact PI · $750K · Fred Hutchinson Cancer Center
- 2016–2021
Role of the Microbiome in HIV Vaccine Induced Heterogeneity
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $3.6M · Fred Hutchinson Cancer Research Center
- 2001–2015
Malaria at the Mother-Child Interface
Fogarty International Center · D43
Contact PI · $131.3K · Seattle Biomedical Research Institute
- 2000–2001
Impact of Ts Prophylaxis on Antifolate Resistant Malaria
Fogarty International Center · K01
Contact PI · $102.6K · University of Maryland Baltimore
Clinical trials
- 2022–2023
Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines
Principal investigator · Completed · Phase 1
Fred Hutchinson Cancer Center
- 2019
Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US
Principal investigator · Completed
PATH
- 2016–2017
DSM265 Prophylaxis of Plasmodium Falciparum Malaria
Principal investigator · Completed · Phase 1
Medicines for Malaria Venture
- 2010–2020
Malaria Clinical Trials Center General Screening
Principal investigator · Completed
Fred Hutchinson Cancer Center